18707823

Source:http://linkedlifedata.com/resource/pubmed/id/18707823

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007137, umls-concept:C0013216, umls-concept:C0205179, umls-concept:C0521115, umls-concept:C1522449
pubmed:issue	4
pubmed:dateCreated	2009-3-2
pubmed:abstractText	To evaluate the feasibility and efficacy of a hyperfractionated accelerated radiotherapy (RT) schedule combined with concomitant chemotherapy (Cx) in patients with locally advanced head-and-neck squamous cell carcinoma.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1879-355X
pubmed:author	pubmed-author:ClementPaul M JPM, pubmed-author:DelaerePierreP, pubmed-author:DirixPietP, pubmed-author:HermansRobertR, pubmed-author:NuytsSandraS, pubmed-author:PoortenVincent VanderVV, pubmed-author:SchoenaersJosephJ, pubmed-author:Van den BogaertWalterW
pubmed:issnType	Electronic
pubmed:day	15
pubmed:volume	73
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1088-95
pubmed:meshHeading	pubmed-meshheading:18707823-Adult, pubmed-meshheading:18707823-Aged, pubmed-meshheading:18707823-Antineoplastic Agents, pubmed-meshheading:18707823-Carcinoma, Squamous Cell, pubmed-meshheading:18707823-Cisplatin, pubmed-meshheading:18707823-Combined Modality Therapy, pubmed-meshheading:18707823-Dose Fractionation, pubmed-meshheading:18707823-Feasibility Studies, pubmed-meshheading:18707823-Female, pubmed-meshheading:18707823-Head and Neck Neoplasms, pubmed-meshheading:18707823-Humans, pubmed-meshheading:18707823-Male, pubmed-meshheading:18707823-Middle Aged
pubmed:year	2009
pubmed:articleTitle	Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
pubmed:affiliation	Department of Radiation Oncology, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium. sandra.nuyts@uzleuven.be
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't